Getting to Yes Consumer Labor and Delivery Model

by Who Decides, What Matters | Series Topic 2 | Jul 31, 2026

Key Insights

After two decades of stalled advocacy, behavioral decision intelligence helped healthcare executives transform a high-risk capital proposal into an evidence-based Board decision.

  • Leadership replaced assumptions based on historical inference with evidence of future market behavior, advancing the proposal to secure approval
  • Historical utilization data showed past choices but provided no clear indication of whether families would switch hospitals - and locations - for a new care model.
  • The key question: would expectant mothers bypass an established suburban leader in favor of a new urban Women & Infants Tower?
  • A discrete choice experiment quantified likely switching behavior and the factors most likely to influence delivery decisions.
  • Predictive simulations estimated incremental deliveries, market-share gains, and financial performance across scenarios.

For more than two decades, a leading pediatric academic medical center’s Chief Medical Officer advocated for a Women & Infants Tower that would integrate labor and delivery with neonatal intensive care, pediatric subspecialists, maternal-fetal medicine, and enhanced patient amenities. The proposal repeatedly stalled because the Board required credible evidence that the tower would generate enough incremental deliveries to justify the hundreds of millions of dollars in construction costs.

Success hinged on whether expectant mothers would bypass the region’s established suburban labor and delivery leader in favor of an unbuilt urban facility. Historical utilization data reflected past choices, not future switching behavior in a market with no comparable facility.

The obstacle was not the vision but uncertainty.

Modeling a Market Before It Exists

MII designed a discrete choice experiment to simulate how families choose where to give birth. Women of childbearing age evaluated realistic delivery options that varied by affiliation, out-of-pocket costs, NICU capabilities, patient safety, room guarantee, family sleeping options, convenience, and patient satisfaction. Their choices indicated whether the proposed tower offered sufficient value to overcome the incumbent’s advantage.

These choices provided new data for decision-making. By simulating future scenarios, leadership could now estimate market share, incremental deliveries, and volume shifts across competing hospitals.

Replacing Assumptions with Decision-Ready Evidence

The simulations provided leaders with market scenarios for comparing against the project’s financial requirements. They also identified the factors most likely to motivate families to switch hospitals, helping executives assess the conditions needed for success. Behavioral decision intelligence turned a twenty-year discussion into a Board-level investment decision grounded in evidence.

The Strategic Value of Knowing What Matters Before Building

Major capital investments often stall when leaders cannot estimate demand in markets that do not yet exist. Behavioral decision intelligence shows where patients are likely to choose tomorrow—and what will influence those choices. For healthcare executives, that can turn a speculative capital debate into a disciplined investment decision.

In the next article in the series, Who Decides. What Matters, we will share what mattered to expectant mothers in Getting to Yes.

Mi4Sight® is Market Innovations, Inc.’s behavioral economics modeling solution. Built on more than 20 years of experience and 135 healthcare studies, it helps leaders test innovative hypotheses, quantify likely behavior, and evaluate investments before committing capital.

To learn more, visit Mi4Sight | Market Innovations Inc.

From Market Health to Decision Intelligence: A New Imperative for Healthcare Leadership

Understanding physician and consumer preferences, service-line growth, vulnerability, and brand health is essential to better strategic decisions. Healthcare executives face a fundamental challenge: making forward-looking strategic decisions based on information that largely describes the past.

Market share, patient volumes, referral patterns, and financial performance remain essential management indicators. However, they cannot fully explain why physicians and consumers choose specific providers, how those preferences may change, or which investments will generate the greatest economic value.

For healthcare leaders, the critical question is not simply how a service line is performing but how healthy its competitive position is—and what leadership can do to strengthen it.

Market Health: Looking Beneath the Number

A service line can show strong historical growth while harboring significant competitive vulnerabilities. Conversely, a program with modest market share may have substantial untapped growth potential.

As discussed in MII's earlier article,  The Decision-making-Blind-spot-for-Healthcare-Providers, referring physicians direct approximately 80% of total volume through referrals across many high-value specialty services, depending on the specialty and the complexity of care.

Understanding physician preferences is therefore essential for simulating service-line growth and vulnerability.

Six dimensions influence physician choice:

  1. Brand: Institutional reputation, clinical credibility, and confidence.
  2. Medical Care: Clinical expertise, outcomes, quality, and care coordination.
  3. Access: Appointment availability, referral processes, and timely treatment.
  4. Price and Billing: Financial considerations, reimbursement, insurance acceptance, and administrative complexity.
  5. Communications and Services: Responsiveness, information exchange, and physician support.
  6. Technology: Advanced equipment, treatment capabilities, and clinical innovation.

Applied behavioral economics quantifies how physicians weigh these attributes when choosing providers, revealing competitive strengths and vulnerabilities that conventional market analysis is not designed to measure.

Translating Market Health into Economic Value

Understanding competitive strengths and weaknesses is only the first step. The greater opportunity is to translate physician and consumer preferences into two critical economic measures:

Growth Potential: How much additional volume and contribution margin could a service line capture by strengthening its competitive position?

Economic Vulnerability: How much existing volume and contribution margin could be lost as physician and consumer preferences shift, or competitors improve their offerings?

An orthopedic program may find that improving access creates greater economic opportunity than expanding capacity. An oncology program may identify referral growth through stronger brand positioning or clinical affiliations. A heart program may uncover substantial vulnerability tied to shifting physician and consumer preferences or competing cardiovascular capabilities.

These insights are difficult to derive from historical performance alone, yet they are central to applied behavioral economics.

From Market Intelligence to Decision Intelligence

Decision Intelligence goes beyond identifying the factors that drive physicians' and consumers' choices. It predicts how they will respond to alternative strategies and translates those responses into economic outcomes.

Discrete choice experiments provide an analytical foundation. By presenting physicians and consumers with realistic alternatives that vary in clinical capabilities, access, technology, brand, and other attributes, discrete choice experiments can be used to build an analytical foundation and quantify the relative influence of each factor on provider selection. The resulting behavioral models enable executives to simulate strategic alternatives well before committing resources.

Would improving orthopedic access generate more economic value than acquiring new surgical technology? Would an oncology affiliation drive greater referral growth than expanding clinical capabilities? Which cardiovascular investments would best protect existing referrals while attracting new ones?

Decision Intelligence connects predicted changes in physician choice to expected volume, contribution margin, investment requirements, and competitive risk.

The strategy that generates the greatest incremental volume may not deliver the greatest economic value when reimbursement, contribution margins, investment costs, and protection of existing business are considered.

A New Leadership Imperative

For healthcare CEOs, CFOs, and strategy executives, this marks a fundamental shift in strategic planning.  Capital is constrained. Competition is intensifying. Strategic decisions have substantial financial consequences.

Historical performance shows leaders where their service lines have been. Market Health reveals the behavioral and competitive forces shaping their future. Decision Intelligence provides the missing link by simulating how strategic alternatives will affect physician behavior, service-line performance, and economic value.

Together, they create a more forward-looking approach to service-line strategy—helping healthcare leaders determine not only where to grow and what to protect, but also which decisions will generate the greatest sustainable economic value.

_________________________________________________________________________________

Mi4Sight® is Market Innovations, Inc.’s behavioral economics modeling solution. Built on more than 20 years of experience and 135 healthcare studies, it helps leaders test innovative hypotheses, quantify likely behavior, and evaluate investments before committing capital. To learn more, visit Mi4sight | Market Innovations Inc.

.